Akari Therapeutics PLC
F:CLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akari Therapeutics PLC
F:CLA
|
US |
|
M
|
Melco Resorts & Entertainment Ltd
F:MAS
|
HK |
|
H
|
Halliburton Co
XMUN:HAL
|
US |
|
H
|
Halliburton Co
XETRA:HAL
|
US |
|
Standard Chartered PLC
LSE:STAN
|
UK |
|
G
|
Greencoat Renewables PLC
LSE:GRP
|
IE |
Shareholder Yield
Current shareholder yield for 
CLA is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CLA Price
Akari Therapeutics PLC
| Average Annual Return | -51.48% |
| Standard Deviation of Annual Returns | 27.23% |
| Max Drawdown | -100% |
| Market Capitalization | 7.8m EUR |
| Shares Outstanding | 3 573 970 000 |
| Percentage of Shares Shorted |
N/A
|
CLA Return Decomposition
Main factors of price return
Stock Splits
CLA's latest stock split occurred on Mar 31, 2026
The company executed a 1-for-40 stock split, meaning that for every 40 shares held, investors received 1 new share.
Before the split, CLA traded at 2.44 per share. Afterward, the share price was about 0.0556.
The adjusted shares began trading on Mar 31, 2026. This was stock split number 2 in CLA's history, following the previous one in Aug 17, 2023.
